Maria Manio, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22320 Meridian Ave E, Graham, WA 98338 Phone: 253-875-1824 |
Mrs. Laura B Lakvold, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 23916 Country Dr E, Graham, WA 98338 Phone: 360-872-0245 |
Corey Vandenboom, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10105 224th St E, Graham, WA 98338 Phone: 253-847-7634 Fax: 253-847-7635 |
Michael Howard Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22320 Meridian Ave E, Graham, WA 98338 Phone: 253-875-1824 |
Wesley Mungal Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22201 Meridian Ave E, Graham, WA 98338 Phone: 954-907-0079 |
Dr. Paul Michael O'reilly, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 10105 224th St E, Graham, WA 98338 Phone: 253-847-7634 Fax: 253-847-7635 |
Mr. James Kung Chun Kao, R.P.H. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 22201 Meridian East, Graham, WA 98338 Phone: 253-846-9455 Fax: 253-846-9462 |
News Archive
Scientists from Würzburg and the US have charted the first global atlas of direct interactions between SARS-CoV-2 RNA and human host cells. This may provide a starting point for novel treatments.
Adolescents don't distinguish between negative emotions as clearly as younger children and adults in their 20s do, according to findings published in Psychological Science, a journal of the Association for Psychological Science. The study sheds light on how experiences of emotion vary at different ages and why adolescence may be a particularly vulnerable period in emotional development.
Once the research team has findings, it will share them with health and social service providers, funders, service users and others to gain their views on what the best methods are and to whom they should be offered.
A new study uses a creative structure-based remodeling strategy to design a therapeutic protein that exhibits significant advantages over currently available treatments for a rare disease that often leads to cardiac and renal failure. The research, published by Cell Press on October 22nd in the American Journal of Human Genetics, describes a new and highly promising candidate for enzyme replacement therapy (ERT) for Fabry disease.
› Verified 1 days ago